Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Polycythemia Vera × Clopidogrel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 1

Interventions

Peripheral Blood Stem Cell Transplantation 2 spartalizumab 1 siltuximab 1 sabatolimab 1 ruxolitinib 1 pelcitoclax 1 fludarabine phosphate 1 ethanolamine oleate 1 durvalumab 1 Whole-Body Irradiation 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Trimethoprim 1 Tacrolimus 1 Sulfamethoxazole 1 Sodium Chloride 1 Saline Solution, Hypertonic 1 Saline Solution 1 Pentostatin 1 Pentetic Acid 1 NIS-793 1 Mycophenolic Acid 1 Methotrexate 1 In Situ Hybridization, Fluorescence 1 Immunoglobulin G 1 Immunoenzyme Techniques 1 Flow Cytometry 1 Filgrastim 1 Ethanol 1 Edetic Acid 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00940784 2014-11-26

ISCLAP

Icahn School of Medicine at Mount Sinai

Phase 2 Withdrawn

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡